Inventaire - your friends and communities are your best library

Long-acting Inhaled β2-Agonists in Asthma Therapy

Published in: Chest

Date of publication: April 1, 1998

Language: English

Main subject: asthma

Bibliographic databases:

Cites articles 149

Date

Title

Authors

May 1, 1978

The response to exercise in normal and asthmatic children
December 1, 1979

An evaluation of pharmacotherapy for exercise-induced asthma
January 1, 1981

Incidence of exercise-induced asthma in adult asthmatics,Incidence of Exercise‐Induced Asthma in Adult Asthmatics
October 1, 1987

Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma
May 1, 1987

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine
September 1, 1988

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients
July 1, 1988

Epidemiology of nocturnal asthma
September 1, 1990

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis
March 1, 1990

Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours
January 1, 1990

Long-term efficacy of formoterol compared to salbutamol
January 1, 1990

Characteristics of bronchodilating activity of formoterol
December 1, 1990

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist
October 1, 1990

Formoterol in the treatment of nocturnal asthma
January 1, 1990

Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma
November 1, 1990

Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction
December 1, 1990

Protection against allergen-induced asthma by salmeterol
September 1, 1990

Guidelines for management of asthma in adults: I--Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign
October 1, 1990

Guidelines for management of asthma in adults: II--Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign
May 1, 1991

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists,The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists
December 1, 1991

Estimation of the efficacy and affinity of the β2-adrenoceptor agonist salmeterol in guinea-pig trachea
November 1, 1991

Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease
June 1, 1991

The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations
September 1, 1991

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma
September 1, 1991

A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects,A Single-dose Comparison of Inhaled Albuterol and Two Formulations of Salmeterol on Airway Reactivity in Asthmatic Subjects
November 1, 1991

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma
May 1, 1991

Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol,Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol
November 1, 1991

Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung
October 1, 1991

Long Duration and High Potency of Antiexudative Effects of Formoterol in Guinea-Pig Tracheobronchial Airways
January 1, 1992

Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding
October 1, 1992

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma
October 1, 1992

Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells
November 1, 1992

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

Article -

Welcome to inventaire

The library of your friends and communities

Learn more